InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by CAPEK JOHN M, Vice-Président Exécutif, Produit. Officer active across 1 companies, notably Abbott Laboratories. In total, 4 disclosures have been recorded. The latest transaction was disclosed on 28 February 2022 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
€775,7747,086 shares@ €109.47980.0004% mcap7.7% of flow
Common shares without par value
SEC:0001415889-22-002188:0·
015,523 shares0
Common shares without par value
SEC:0001415889-22-001732:0·
€5m149,600 shares@ €30.8880.0021% mcap100.0% of flow
Common shares without par value
SEC:0001415889-21-005966·
€5m149,600 shares@ €30.8880.0021% mcap46.1% of flow
Common shares without par value
SEC:0001415889-21-005966:0·
4 of 4 declarations
About CAPEK JOHN M
CAPEK JOHN M is the Chief Product Officer & EVP at ABBOTT LABORATORIES. He oversees product development and management, ensuring innovation and quality. John brings expertise in the pharmaceutical sector, contributing to improving healthcare.
